BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 6871863)

  • 1. Kinetics of diethylnitrosamine hepatocarcinogenesis in the infant mouse.
    Vesselinovitch SD; Mihailovich N
    Cancer Res; 1983 Sep; 43(9):4253-9. PubMed ID: 6871863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histochemical characterization of focal hepatic lesions induced by single diethylnitrosamine treatment in infant mice.
    Vesselinovitch SD; Hacker HJ; Bannasch P
    Cancer Res; 1985 Jun; 45(6):2774-80. PubMed ID: 2859111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rat hepatocarcinogenesis induced by N-nitrosodiethylamine and N-nitrosomorpholine continuously administered at low doses. From basophilic areas of hepatocytes to hepatocellular tumors.
    Cortinovis C; Klimek F; Nogueira E
    Am J Pathol; 1991 Nov; 139(5):1157-71. PubMed ID: 1951631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histochemical profile of mouse hepatocellular adenomas and carcinomas induced by a single dose of diethylnitrosamine.
    Hacker HJ; Mtiro H; Bannasch P; Vesselinovitch SD
    Cancer Res; 1991 Apr; 51(7):1952-8. PubMed ID: 1848480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic foci of cellular and enzymatic alteration and nodules in rats treated with clofibrate or diethylnitrosamine followed by phenobarbital: their rate of onset and their reversibility.
    Greaves P; Irisarri E; Monro AM
    J Natl Cancer Inst; 1986 Mar; 76(3):475-84. PubMed ID: 2869179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multi-hit kinetics of tumor formation, with special reference to experimental liver and human lung carcinogenesis and some gneral conclusions.
    Emmelot P; Scherer E
    Cancer Res; 1977 Jun; 37(6):1702-8. PubMed ID: 870184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diethyl-nitrosamine hepatocarcinogenesis in cirrhotic rats.
    Zalatnai A; Lapis K
    Acta Morphol Hung; 1987; 35(3-4):211-8. PubMed ID: 3137785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose and time relationships for tumor induction in the liver and esophagus of 4080 inbred rats by chronic ingestion of N-nitrosodiethylamine or N-nitrosodimethylamine.
    Peto R; Gray R; Brantom P; Grasso P
    Cancer Res; 1991 Dec; 51(23 Pt 2):6452-69. PubMed ID: 1933907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Focal impairment of growth in hepatocellular neoplasms of C57BL/6 mice: a possible explanation for the strain's resistance to hepatocarcinogenesis.
    Kakizoe S; Goldfarb S; Pugh TD
    Cancer Res; 1989 Jul; 49(14):3985-9. PubMed ID: 2736537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Continued development of hepatic gamma-glutamyltranspeptidase-positive foci upon withdrawal of 17 alpha-ethynylestradiol in diethylnitrosamine-initiated rats.
    Campen DB; Sloop TC; Maronpot RR; Lucier GW
    Cancer Res; 1987 May; 47(9):2328-33. PubMed ID: 2882836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The induction of esophageal tumors in mice: dose and time dependency.
    Rubio CA; Liu FS; Chejfec G; Sveander M
    In Vivo; 1987; 1(1):35-8. PubMed ID: 2979761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antigenic relationship between oval cells and a subpopulation of hepatic foci, nodules, and carcinomas induced by the "resistant hepatocyte" model system.
    Faris RA; Monfils BA; Dunsford HA; Hixson DC
    Cancer Res; 1991 Feb; 51(4):1308-17. PubMed ID: 1997169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth kinetics of microscopic hepatocellular neoplasms in carcinogen-resistant and carcinogen-responsive strains of mice.
    Pugh TD; Goldfarb S
    Cancer Res; 1992 Jan; 52(2):280-4. PubMed ID: 1728402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid emergence of carcinogen-induced hyperplastic lesions in a new model for the sequential analysis of liver carcinogenesis.
    Solt DB; Medline A; Farber E
    Am J Pathol; 1977 Sep; 88(3):595-618. PubMed ID: 18937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Morphology and metastatic nature of induced hepatic nodular lesions in C57BL x C3H F1 mice.
    Vesselinovitch SD; Mihailovich N; Rao KV
    Cancer Res; 1978 Jul; 38(7):2003-10. PubMed ID: 207419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Membrane enzyme cytochemical changes in the hepatocytes of diethylnitrosamine induced hepatomas.
    Krustev LP; Mizinska-Boevska YD; Poljakova-Krusteva OT
    Arch Geschwulstforsch; 1985; 55(2):99-105. PubMed ID: 2988480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histogenesis of dieldrin and DDT-induced hepatocellular carcinoma in Balb/c mice.
    Lipsky MM; Trump BF; Hinton DE
    J Environ Pathol Toxicol Oncol; 1989; 9(1):79-93. PubMed ID: 2564434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progressive atypia in spontaneous and N-nitrosodiethylamine-induced hepatocellular adenomas of C3H/HeNCr mice.
    Jang JJ; Weghorst CM; Henneman JR; Devor DE; Ward JM
    Carcinogenesis; 1992 Sep; 13(9):1541-7. PubMed ID: 1394837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of diethylnitrosamine on the livers of rats after high oral doses administered at intervals varying between three and twenty-four days.
    Steinhoff D
    Acta Hepatogastroenterol (Stuttg); 1975 Apr; 22(2):72-7. PubMed ID: 165650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose-response relationships in promotion of rat hepatocarcinogenesis by 17 alpha-ethinylestradiol.
    Campen D; Maronpot R; Lucier G
    J Toxicol Environ Health; 1990; 29(3):257-68. PubMed ID: 1968981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.